Skip to main content
Top
Published in: Diagnostic Pathology 1/2012

Open Access 01-12-2012 | Research

The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomas

Authors: Xiaoming Xu, Huiying Jin, Yafang Liu, Li Liu, Qiong Wu, Yaxiong Guo, Lina Yu, Zhijing Liu, Ting Zhang, Xiaowei Zhang, Xueyan Dong, Chengshi Quan

Published in: Diagnostic Pathology | Issue 1/2012

Login to get access

Abstract

Background

Claudin-6 is a candidate tumor suppressor gene in breast cancer, and has been shown to be regulated by DNA methylation and histone modification in breast cancer lines. However, the expression of claudin-6 in breast invasive ductal carcinomas and correlation with clinical behavior or expression of other markers is unclear. We considered that the expression pattern of claudin-6 might be related to the expression of DNA methylation associated proteins (methyl-CpG binding protein 2 (MeCP2) and DNA methyltransferase 1 (DNMT1)) and histone modification associated proteins (histone deacetylase 1 (HDAC1), acetyl-histone H3 (H3Ac) and acetyl- histone H4 (H4Ac)).

Methods

We have investigated the expression of claudin-6, MeCP2, HDAC1, H3Ac and H4Ac in 100 breast invasive ductal carcinoma tissues and 22 mammary gland fibroadenoma tissues using immunohistochemistry.

Results

Claudin-6 protein expression was reduced in breast invasive ductal carcinomas (P < 0.001). In contrast, expression of MeCP2 (P < 0.001), DNMT1 (P = 0.001), HDAC1 (P < 0.001) and H3Ac (P = 0.004) expressions was increased. Claudin-6 expression was inversely correlated with lymph node metastasis (P = 0.021). Increased expression of HDAC1 was correlated with histological grade (P < 0.001), age (P = 0.004), clinical stage (P = 0.007) and lymph node metastasis (P = 0.001). H3Ac expression was associated with tumor size (P = 0.044) and clinical stage of cancers (P = 0.034). MeCP2, DNMT1 and H4Ac expression levels did not correlate with any of the tested clinicopathological parameters (P > 0.05). We identified a positive correlation between MeCP2 protein expression and H3Ac and H4Ac protein expression.

Conclusions

Our results show that claudin-6 protein is significantly down-regulated in breast invasive ductal carcinomas and is an important correlate with lymphatic metastasis, but claudin-6 down-regulation was not correlated with upregulation of the methylation associated proteins (MeCP2, DNMT1) or histone modification associated proteins (HDAC1, H3Ac, H4Ac). Interestingly, the expression of MeCP2 was positively correlated with the expression of H3Ac and H3Ac protein expression was positively correlated with the expression of H4Ac in breast invasive ductal carcinoma

Virtual slides

Appendix
Available only for authorised users
Literature
1.
go back to reference Warner E: Clinical practice. Breast-cancer screening. N Engl J Med. 2011, 365 (11): 1025-1032. 10.1056/NEJMcp1101540.CrossRefPubMed Warner E: Clinical practice. Breast-cancer screening. N Engl J Med. 2011, 365 (11): 1025-1032. 10.1056/NEJMcp1101540.CrossRefPubMed
2.
go back to reference Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S: Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene. 2003, 22 (13): 2021-2033. 10.1038/sj.onc.1206199.CrossRefPubMed Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S: Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene. 2003, 22 (13): 2021-2033. 10.1038/sj.onc.1206199.CrossRefPubMed
3.
go back to reference Escudero-Esparza A, Jiang WG, Martin TA: The Claudin family and its role in cancer and metastasis. Front Biosci. 2011, 16: 1069-1083. 10.2741/3736.CrossRef Escudero-Esparza A, Jiang WG, Martin TA: The Claudin family and its role in cancer and metastasis. Front Biosci. 2011, 16: 1069-1083. 10.2741/3736.CrossRef
4.
go back to reference Mineta K, Yamamoto Y, Yamazaki Y, Tanaka H, Tada Y, Saito K, Tamura A, Igarashi M, Endo T, Takeuchi K, et al.: Predicted expansion of the claudin multigene family. FEBS Lett. 2011, 585 (4): 606-612. 10.1016/j.febslet.2011.01.028.CrossRefPubMed Mineta K, Yamamoto Y, Yamazaki Y, Tanaka H, Tada Y, Saito K, Tamura A, Igarashi M, Endo T, Takeuchi K, et al.: Predicted expansion of the claudin multigene family. FEBS Lett. 2011, 585 (4): 606-612. 10.1016/j.febslet.2011.01.028.CrossRefPubMed
5.
go back to reference Turksen K, Troy TC: Junctions gone bad: claudins and loss of the barrier in cancer. Biochim Biophys Acta. 2011, 1816 (1): 73-79.PubMed Turksen K, Troy TC: Junctions gone bad: claudins and loss of the barrier in cancer. Biochim Biophys Acta. 2011, 1816 (1): 73-79.PubMed
6.
go back to reference Turksen K, Troy TC: Claudin-6: a novel tight junction molecule is developmentally regulated in mouse embryonic epithelium. Dev Dyn. 2001, 222 (2): 292-300. 10.1002/dvdy.1174.CrossRefPubMed Turksen K, Troy TC: Claudin-6: a novel tight junction molecule is developmentally regulated in mouse embryonic epithelium. Dev Dyn. 2001, 222 (2): 292-300. 10.1002/dvdy.1174.CrossRefPubMed
8.
go back to reference Kwon MJ, Kim SS, Choi YL, Jung HS, Balch C, Kim SH, Song YS, Marquez VE, Nephew KP, Shin YK: Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications. Carcinogenesis. 2010, 31 (6): 974-983. 10.1093/carcin/bgp336.PubMedCentralCrossRefPubMed Kwon MJ, Kim SS, Choi YL, Jung HS, Balch C, Kim SH, Song YS, Marquez VE, Nephew KP, Shin YK: Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications. Carcinogenesis. 2010, 31 (6): 974-983. 10.1093/carcin/bgp336.PubMedCentralCrossRefPubMed
9.
go back to reference Honda H, Pazin MJ, Ji H, Wernyj RP, Morin PJ: Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells. J Biol Chem. 2006, 281 (30): 21433-21444. 10.1074/jbc.M603767200.CrossRefPubMed Honda H, Pazin MJ, Ji H, Wernyj RP, Morin PJ: Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells. J Biol Chem. 2006, 281 (30): 21433-21444. 10.1074/jbc.M603767200.CrossRefPubMed
10.
11.
go back to reference Veeck J, Esteller M: Breast cancer epigenetics: from DNA methylation to microRNAs. J Mammary Gland Biol Neoplasia. 2010, 15 (1): 5-17. 10.1007/s10911-010-9165-1.PubMedCentralCrossRefPubMed Veeck J, Esteller M: Breast cancer epigenetics: from DNA methylation to microRNAs. J Mammary Gland Biol Neoplasia. 2010, 15 (1): 5-17. 10.1007/s10911-010-9165-1.PubMedCentralCrossRefPubMed
12.
go back to reference Yang X, Yan L, Davidson NE: DNA methylation in breast cancer. Endocr Relat Cancer. 2001, 8 (2): 115-127. 10.1677/erc.0.0080115.CrossRefPubMed Yang X, Yan L, Davidson NE: DNA methylation in breast cancer. Endocr Relat Cancer. 2001, 8 (2): 115-127. 10.1677/erc.0.0080115.CrossRefPubMed
13.
go back to reference Kouzarides T: Chromatin modifications and their function. Cell. 2007, 128 (4): 693-705. 10.1016/j.cell.2007.02.005.CrossRefPubMed Kouzarides T: Chromatin modifications and their function. Cell. 2007, 128 (4): 693-705. 10.1016/j.cell.2007.02.005.CrossRefPubMed
14.
go back to reference Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M, Kurdistani SK: Global histone modification patterns predict risk of prostate cancer recurrence. Nature. 2005, 435 (7046): 1262-1266. 10.1038/nature03672.CrossRefPubMed Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M, Kurdistani SK: Global histone modification patterns predict risk of prostate cancer recurrence. Nature. 2005, 435 (7046): 1262-1266. 10.1038/nature03672.CrossRefPubMed
15.
go back to reference Lagger G, O'Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, Schuettengruber B, Hauser C, Brunmeir R, Jenuwein T, et al.: Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 2002, 21 (11): 2672-2681. 10.1093/emboj/21.11.2672.PubMedCentralCrossRefPubMed Lagger G, O'Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, Schuettengruber B, Hauser C, Brunmeir R, Jenuwein T, et al.: Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 2002, 21 (11): 2672-2681. 10.1093/emboj/21.11.2672.PubMedCentralCrossRefPubMed
16.
go back to reference Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 2002, 41 (3A): 154-161.CrossRefPubMed Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 2002, 41 (3A): 154-161.CrossRefPubMed
17.
go back to reference Yafang L, Qiong W, Yue R, Xiaoming X, Lina Y, Mingzi Z, Ting Z, Yulin L, Chengshi Q: Role of Estrogen Receptor-alpha in the Regulation of Claudin-6 Expression in Breast Cancer Cells. J Breast Cancer. 2011, 14 (1): 20-27. 10.4048/jbc.2011.14.1.20.PubMedCentralCrossRefPubMed Yafang L, Qiong W, Yue R, Xiaoming X, Lina Y, Mingzi Z, Ting Z, Yulin L, Chengshi Q: Role of Estrogen Receptor-alpha in the Regulation of Claudin-6 Expression in Breast Cancer Cells. J Breast Cancer. 2011, 14 (1): 20-27. 10.4048/jbc.2011.14.1.20.PubMedCentralCrossRefPubMed
18.
go back to reference Peng DF, Kanai Y, Sawada M, Ushijima S, Hiraoka N, Kosuge T, Hirohashi S: Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Cancer Sci. 2005, 96 (7): 403-408. 10.1111/j.1349-7006.2005.00071.x.CrossRefPubMed Peng DF, Kanai Y, Sawada M, Ushijima S, Hiraoka N, Kosuge T, Hirohashi S: Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Cancer Sci. 2005, 96 (7): 403-408. 10.1111/j.1349-7006.2005.00071.x.CrossRefPubMed
19.
go back to reference Saito Y, Kanai Y, Nakagawa T, Sakamoto M, Saito H, Ishii H, Hirohashi S: Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer. 2003, 105 (4): 527-532. 10.1002/ijc.11127.CrossRefPubMed Saito Y, Kanai Y, Nakagawa T, Sakamoto M, Saito H, Ishii H, Hirohashi S: Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer. 2003, 105 (4): 527-532. 10.1002/ijc.11127.CrossRefPubMed
20.
go back to reference Rikimaru T, Taketomi A, Yamashita Y, Shirabe K, Hamatsu T, Shimada M, Maehara Y: Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma. Oncology. 2007, 72 (1-2): 69-74. 10.1159/000111106.CrossRefPubMed Rikimaru T, Taketomi A, Yamashita Y, Shirabe K, Hamatsu T, Shimada M, Maehara Y: Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma. Oncology. 2007, 72 (1-2): 69-74. 10.1159/000111106.CrossRefPubMed
21.
go back to reference Quan C, Lu SJ: Identification of genes preferentially expressed in mammary epithelial cells of Copenhagen rat using subtractive hybridization and microarrays. Carcinogenesis. 2003, 24 (10): 1593-1599. 10.1093/carcin/bgg129.CrossRefPubMed Quan C, Lu SJ: Identification of genes preferentially expressed in mammary epithelial cells of Copenhagen rat using subtractive hybridization and microarrays. Carcinogenesis. 2003, 24 (10): 1593-1599. 10.1093/carcin/bgg129.CrossRefPubMed
22.
go back to reference Wu Q, Liu Y, Ren Y, Xu X, Yu L, Li Y, Quan C: Tight junction protein, claudin-6, downregulates the malignant phenotype of breast carcinoma. Eur J Cancer Prev. 2010, 19 (3): 186-194. 10.1097/CEJ.0b013e328337210e.CrossRefPubMed Wu Q, Liu Y, Ren Y, Xu X, Yu L, Li Y, Quan C: Tight junction protein, claudin-6, downregulates the malignant phenotype of breast carcinoma. Eur J Cancer Prev. 2010, 19 (3): 186-194. 10.1097/CEJ.0b013e328337210e.CrossRefPubMed
23.
go back to reference Osanai M, Murata M, Chiba H, Kojima T, Sawada N: Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells. Cancer Sci. 2007, 98 (10): 1557-1562. 10.1111/j.1349-7006.2007.00569.x.CrossRefPubMed Osanai M, Murata M, Chiba H, Kojima T, Sawada N: Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells. Cancer Sci. 2007, 98 (10): 1557-1562. 10.1111/j.1349-7006.2007.00569.x.CrossRefPubMed
24.
go back to reference Bird A: The methyl-CpG-binding protein MeCP2 and neurological disease. Biochem Soc Trans. 2008, 36 (Pt 4): 575-583.CrossRefPubMed Bird A: The methyl-CpG-binding protein MeCP2 and neurological disease. Biochem Soc Trans. 2008, 36 (Pt 4): 575-583.CrossRefPubMed
25.
go back to reference Hua X, Yu L, Huang X, Liao Z, Xian Q: Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma. Diagn Pathol. 2011, 6: 111-10.1186/1746-1596-6-111.PubMedCentralCrossRefPubMed Hua X, Yu L, Huang X, Liao Z, Xian Q: Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma. Diagn Pathol. 2011, 6: 111-10.1186/1746-1596-6-111.PubMedCentralCrossRefPubMed
26.
go back to reference Antonelli M, Hasselblatt M, Haberler C, Di Giannatale A, Garre ML, Donofrio V, Lauriola L, Ridola V, Arcella A, Fruhwald M, et al.: Claudin-6 is of limited sensitivity and specificity for the diagnosis of atypical teratoid/rhabdoid tumors. Brain Pathol. 2011, 21 (5): 558-563.PubMed Antonelli M, Hasselblatt M, Haberler C, Di Giannatale A, Garre ML, Donofrio V, Lauriola L, Ridola V, Arcella A, Fruhwald M, et al.: Claudin-6 is of limited sensitivity and specificity for the diagnosis of atypical teratoid/rhabdoid tumors. Brain Pathol. 2011, 21 (5): 558-563.PubMed
27.
go back to reference Ouban A, Ahmed AA: Claudins in human cancer: a review. Histol Histopathol. 2010, 25 (1): 83-90.PubMed Ouban A, Ahmed AA: Claudins in human cancer: a review. Histol Histopathol. 2010, 25 (1): 83-90.PubMed
28.
go back to reference Schneppenheim R, Fruhwald MC, Gesk S, Hasselblatt M, Jeibmann A, Kordes U, Kreuz M, Leuschner I, Martin Subero JI, Obser T, et al.: Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet. 2010, 86 (2): 279-284. 10.1016/j.ajhg.2010.01.013.PubMedCentralCrossRefPubMed Schneppenheim R, Fruhwald MC, Gesk S, Hasselblatt M, Jeibmann A, Kordes U, Kreuz M, Leuschner I, Martin Subero JI, Obser T, et al.: Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet. 2010, 86 (2): 279-284. 10.1016/j.ajhg.2010.01.013.PubMedCentralCrossRefPubMed
29.
go back to reference Brenner C, Fuks F: DNA methyltransferases: facts, clues, mysteries. Curr Top Microbiol Immunol. 2006, 301: 45-66. 10.1007/3-540-31390-7_3.PubMed Brenner C, Fuks F: DNA methyltransferases: facts, clues, mysteries. Curr Top Microbiol Immunol. 2006, 301: 45-66. 10.1007/3-540-31390-7_3.PubMed
30.
go back to reference Bogdanovic O, Veenstra GJ: DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma. 2009, 118 (5): 549-565. 10.1007/s00412-009-0221-9.PubMedCentralCrossRefPubMed Bogdanovic O, Veenstra GJ: DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma. 2009, 118 (5): 549-565. 10.1007/s00412-009-0221-9.PubMedCentralCrossRefPubMed
31.
go back to reference Wojdacz TK, Thestrup BB, Overgaard J, Hansen LL: Methylation of cancer related genes in tumor and peripheral blood DNA from the same breast cancer patient as two independent events. Diagn Pathol. 2011, 6: 116-10.1186/1746-1596-6-116.PubMedCentralCrossRefPubMed Wojdacz TK, Thestrup BB, Overgaard J, Hansen LL: Methylation of cancer related genes in tumor and peripheral blood DNA from the same breast cancer patient as two independent events. Diagn Pathol. 2011, 6: 116-10.1186/1746-1596-6-116.PubMedCentralCrossRefPubMed
32.
go back to reference Muller HM, Fiegl H, Goebel G, Hubalek MM, Widschwendter A, Muller-Holzner E, Marth C, Widschwendter M: MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status. Br J Cancer. 2003, 89 (10): 1934-1939. 10.1038/sj.bjc.6601392.PubMedCentralCrossRefPubMed Muller HM, Fiegl H, Goebel G, Hubalek MM, Widschwendter A, Muller-Holzner E, Marth C, Widschwendter M: MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status. Br J Cancer. 2003, 89 (10): 1934-1939. 10.1038/sj.bjc.6601392.PubMedCentralCrossRefPubMed
33.
go back to reference Nan X, Campoy FJ, Bird A: MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell. 1997, 88 (4): 471-481. 10.1016/S0092-8674(00)81887-5.CrossRefPubMed Nan X, Campoy FJ, Bird A: MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell. 1997, 88 (4): 471-481. 10.1016/S0092-8674(00)81887-5.CrossRefPubMed
34.
go back to reference Magdinier F, Billard LM, Wittmann G, Frappart L, Benchaib M, Lenoir GM, Guerin JF, Dante R: Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells. FASEB J. 2000, 14 (11): 1585-1594. 10.1096/fj.14.11.1585.CrossRefPubMed Magdinier F, Billard LM, Wittmann G, Frappart L, Benchaib M, Lenoir GM, Guerin JF, Dante R: Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells. FASEB J. 2000, 14 (11): 1585-1594. 10.1096/fj.14.11.1585.CrossRefPubMed
35.
go back to reference Wischnewski F, Friese O, Pantel K, Schwarzenbach H: Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters. Mol Cancer Res. 2007, 5 (7): 749-759. 10.1158/1541-7786.MCR-06-0364.CrossRefPubMed Wischnewski F, Friese O, Pantel K, Schwarzenbach H: Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters. Mol Cancer Res. 2007, 5 (7): 749-759. 10.1158/1541-7786.MCR-06-0364.CrossRefPubMed
36.
go back to reference Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP: Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet. 1998, 19 (2): 187-191. 10.1038/561.CrossRefPubMed Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP: Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet. 1998, 19 (2): 187-191. 10.1038/561.CrossRefPubMed
37.
go back to reference Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 1998, 393 (6683): 386-389. 10.1038/30764.CrossRefPubMed Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 1998, 393 (6683): 386-389. 10.1038/30764.CrossRefPubMed
38.
go back to reference Segre CV, Chiocca S: Regulating the regulators: the post-translational code of class I HDAC1 and HDAC2. J Biomed Biotechnol. 2010, 2011: 690848-PubMedCentralPubMed Segre CV, Chiocca S: Regulating the regulators: the post-translational code of class I HDAC1 and HDAC2. J Biomed Biotechnol. 2010, 2011: 690848-PubMedCentralPubMed
39.
go back to reference Weichert W, Roske A, Gekeler V, Beckers T, Ebert MP, Pross M, Dietel M, Denkert C, Rocken C: Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis. Lancet Oncol. 2008, 9 (2): 139-148. 10.1016/S1470-2045(08)70004-4.CrossRefPubMed Weichert W, Roske A, Gekeler V, Beckers T, Ebert MP, Pross M, Dietel M, Denkert C, Rocken C: Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis. Lancet Oncol. 2008, 9 (2): 139-148. 10.1016/S1470-2045(08)70004-4.CrossRefPubMed
40.
go back to reference Weichert W, Roske A, Niesporek S, Noske A, Buckendahl AC, Dietel M, Gekeler V, Boehm M, Beckers T, Denkert C: Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin Cancer Res. 2008, 14 (6): 1669-1677. 10.1158/1078-0432.CCR-07-0990.CrossRefPubMed Weichert W, Roske A, Niesporek S, Noske A, Buckendahl AC, Dietel M, Gekeler V, Boehm M, Beckers T, Denkert C: Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin Cancer Res. 2008, 14 (6): 1669-1677. 10.1158/1078-0432.CCR-07-0990.CrossRefPubMed
41.
go back to reference Miyake K, Yoshizumi T, Imura S, Sugimoto K, Batmunkh E, Kanemura H, Morine Y, Shimada M: Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation. Pancreas. 2008, 36 (3): e1-e9. 10.1097/MPA.0b013e31815f2c2a.CrossRefPubMed Miyake K, Yoshizumi T, Imura S, Sugimoto K, Batmunkh E, Kanemura H, Morine Y, Shimada M: Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation. Pancreas. 2008, 36 (3): e1-e9. 10.1097/MPA.0b013e31815f2c2a.CrossRefPubMed
42.
go back to reference Krusche CA, Wulfing P, Kersting C, Vloet A, Bocker W, Kiesel L, Beier HM, Alfer J: Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis. Breast Cancer Res Treat. 2005, 90 (1): 15-23. 10.1007/s10549-004-1668-2.CrossRefPubMed Krusche CA, Wulfing P, Kersting C, Vloet A, Bocker W, Kiesel L, Beier HM, Alfer J: Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis. Breast Cancer Res Treat. 2005, 90 (1): 15-23. 10.1007/s10549-004-1668-2.CrossRefPubMed
Metadata
Title
The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomas
Authors
Xiaoming Xu
Huiying Jin
Yafang Liu
Li Liu
Qiong Wu
Yaxiong Guo
Lina Yu
Zhijing Liu
Ting Zhang
Xiaowei Zhang
Xueyan Dong
Chengshi Quan
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2012
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-7-33

Other articles of this Issue 1/2012

Diagnostic Pathology 1/2012 Go to the issue